BNTC icon

Benitec Biopharma
BNTC

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $3.9M invested in Benitec Biopharma in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

2.93% less ownership

Funds ownership: 49.72% → 46.8% (-2.9%)

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$53.9K
2
+$32.9K
3
+$7.43K
4
UBS Group
UBS Group
Switzerland
+$1.66K
5
Wells Fargo
Wells Fargo
California
+$13

Top Sellers

1
-$210K
2
-$84.1K
3
-$70
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.91M
2
$660K
3
$611K
4
$589K
5
$53.9K
6
$32.9K
7
$32.5K
8
$8.06K
9
$2.01K
10
$947
11
$602
12
$288
13
$55
14
–
15
–